This article is available online at http://www.jlr.org dramatically in the past 20 years, in parallel with the epidemic of obesity. Although environmental factors (caloric excess) and lifestyle choices (lack of exercise) are the primary causes, genetic susceptibility also predisposes individuals to obesity and its metabolic complications. Studies have identifi ed mechanisms by which food consumption is regulated, including release of factors produced within the gastrointestinal tract (CCK, ghrelin, PYY, lipid amides, and palmitoleic acid) that mediate satiety either locally or centrally ( 1 ).Recent studies have identifi ed several lipid messengers that regulate feeding behavior ( 2-5 ). These include the endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (endogenous ligands of the cannabinoid receptors); the fatty acid ethanolamides (FAE), oleoylethanolamide (OEA) and palmitoylethanolamide (PEA); and their biosynthetic precursors, the N -acyl-phosphatidylethanolamines ( 6, 7 ). OEA is an ubiquitous lipid molecule that is synthesized in the proximal small intestine following consumption of dietary fat, and it promotes satiety by binding nuclear peroxisome proliferator-activated receptor-␣ (PPAR ␣ ) and activating vagal efferents ( 8-10 ). Conversely, AEA promotes food consumption through activation of CB 1 cannabinoid receptors both in the brain and peripheral tissues. In addition, AEA regulates systemic energy utilization, infl ammation, apoptosis, and pain ( 11, 12 ). Details of how the balance between opposing satiety and orexigenic factors is maintained are a focus of investigation, but there is increasing evidence for a role of intracellular The prevalence of nonalcoholic fatty liver disease, type II diabetes, and the metabolic syndrome has increased